Evidence map›Paper›PMID 35610401›Full record

ArticleMolecular and cellular biochemistry2022

Zinc and hypoxic preconditioning: a strategy to enhance the functionality and therapeutic potential of bone marrow-derived mesenchymal stem cells.

Syed Faizan Ali Rizvi, Bushra Wasim, Shumaila Usman, Kevin Joseph Jerome Borges, Iqra Sahibdad, Asmat Salim, Irfan Khan

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular and cellular biochemistry, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Syed Faizan Ali RizviGhulam Muhammad Mahar Medical College Sukkur at Shaheed Mohtarma Benazir Bhutto Medical University Larkana, Larkana, 77150, Pakistan.
Bushra WasimZiauddin University, Clifton, Karachi, 74700, Pakistan.
Shumaila UsmanZiauddin University, Clifton, Karachi, 74700, Pakistan.
Kevin Joseph Jerome BorgesZiauddin University, Clifton, Karachi, 74700, Pakistan.
Iqra SahibdadDr. Panjwani Center for Molecular Medicine and Drug Research, International Centre for Chemical and Biological Sciences, Karachi, 75270, Pakistan.
Asmat SalimDr. Panjwani Center for Molecular Medicine and Drug Research, International Centre for Chemical and Biological Sciences, Karachi, 75270, Pakistan.
Irfan KhanDr. Panjwani Center for Molecular Medicine and Drug Research, International Centre for Chemical and Biological Sciences, Karachi, 75270, Pakistan. khan@iccs.edu.ORCID http://orcid.org/0000-0003-1878-7836
Ziauddin University · PKInternational Center for Chemical and Biological Sciences · PKShaheed Mohtarma Benazir Bhutto Medical University · PKUniversity of Karachi · PK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The therapeutic use of bone marrow mesenchymal stem cells (BM-MSCs) requires a large number of cells (1-100 × 10

Indexed as

Bone Marrow CellsMesenchymal Stem CellsAgedBone MarrowCell HypoxiaCell ProliferationCells, CulturedHumansHypoxiaZincZincHIF-1αHypoxiaLate passagesMesenchymal stem cellsMorphologyProliferation

Identifiers

PMID35610401
OpenAlexW4281382093

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.